CME Group Inc. (CME) Stock Price & Analysis
CME Group Inc. (CME) closed at USD 305.98 on Thursday, October 22, 2026, up 3.45% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 295.79; the Oct 22, 2026 session ranged USD 300–307.26 on volume of 2,294,409 shares. Market capitalization is $110.02B, with a 52-week range of USD 218.31–329.16 (NMS). Source: Nexqual, retrieved October 23, 2026 at 09:16 UTC.
Also available as compact Markdown for AI agents: nexqual.com/CME.md
Latest Earnings Results (CME)
CME Group Inc. (CME) reported Q3 2026 results on Oct 21, 2026, 7:13:51 AM ET: adjusted EPS $3.02 vs. estimate $2.99 (beat), revenue $1.74B vs. estimate $1.72B (beat). Source: SEC 8-K filing. Nexqual published it 42 seconds after release. Read the SEC filing.
| Fiscal period | EPS (reported) | Revenue | Released | Source |
|---|---|---|---|---|
| Q3 2026 | $3.02 (adjusted (non-GAAP) diluted) | $1.74B | Oct 21, 2026, 7:13:51 AM ET · on Nexqual +42 seconds | SEC 8-K filing |
Reported actuals captured by Nexqual from SEC 8-K filings and company press releases; each figure confirmed by two independent extraction methods.
Key facts (CME)
- Last four reported quarters (through Jun 30, 2026): revenue $6.77B, net income $4.29B (63.3% margin), free cash flow $4.21B (SEC filings).
- Valuation: P/E 25.7x (avg 23.8x at the last 3 fiscal year-ends).
- 7 of 80 tracked superinvestors hold CME (13F, Q2 2026): 3 new, 1 added, 1 reduced, 2 unchanged.
- Analysts: Buy (mean 2.35 on a 1–5 scale) (17 analysts), mean target USD 313.81 (range 227–367).
- Total return with dividends: 1Y +18.2% vs S&P 500 +14.9%; 5Y +73.2% vs S&P 500 +80.3%.
- Next earnings: 2026-10-21, EPS estimate USD 3.03, revenue estimate $1.77B.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (CME)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $4.69B | $5.02B | $5.58B | $6.13B | $6.52B | $6.77B |
| Operating income | $2.65B | $3.02B | $3.44B | $3.93B | $4.23B | $4.41B |
| Net income | $2.64B | $2.69B | $3.23B | $3.53B | $4.07B | $4.29B |
| EPS (diluted) | $7.29 | $7.40 | $8.86 | $9.67 | $11.16 | — |
| Free cash flow | $2.28B | $2.97B | $3.38B | $3.60B | $4.19B | $4.21B |
| Operating margin | 56.4% | 60.1% | 61.6% | 64.1% | 64.9% | 65.1% |
| Net margin | 56.2% | 53.6% | 57.8% | 57.5% | 62.5% | 63.3% |
| Revenue growth | -4.0% | +7.0% | +11.1% | +9.9% | +6.4% | — |
| Cash + short-term investments | $2.95B | $2.82B | $3.02B | $3.01B | $4.54B | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (CME)
P/E 25.7x · P/S 16.3x · P/FCF 26.1x · P/B 4.2x · FCF yield 3.83% · Earnings yield 3.90% · Dividend yield (paid, TTM) 3.70%
P/E at fiscal year-ends: Dec 2025 24.2x, Dec 2024 23.7x, Dec 2023 23.5x.
Superinvestors (SEC 13F-HR, Q2 2026) (CME)
7 of 80 tracked investors hold CME. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Seth Klarman | Baupost Group | 2.52% | $137M | New position |
| William Von Mueffling | Cantillon Capital Management | 2.12% | $14.1M | Reduced -95.4% |
| Van Den Berg Management I | 1.03% | $4.9M | Added +19.4% | |
| Mairs & Power | Mairs & Power Funds | 0.40% | $43.2M | New position |
| Viking Global | Viking Global Investors | 0.10% | $33.8M | New position |
| Thomas Gayner | Markel Group | 0.08% | $11.0M | Unchanged |
| Lindsell Train | 0.06% | $1.5M | Unchanged |
Analysts (CME)
Consensus Buy (mean 2.35 on a 1–5 scale), 17 analysts; mean target USD 313.81 (low 227, high 367).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-22 | UBS | Target raised | Neutral | $270 → $310 |
| 2026-10-22 | Morgan Stanley | Target raised | Overweight | $337 → $359 |
| 2026-10-22 | Barclays | Target raised | Equal-Weight | $281 → $321 |
| 2026-10-22 | Wells Fargo | Target raised | Overweight | $315 → $333 |
| 2026-10-22 | Piper Sandler | Target raised | Overweight | $295 → $330 |
| 2026-10-22 | JP Morgan | Upgrade | Underweight → Overweight | $367 |
| 2026-10-14 | Wells Fargo | Target raised | Overweight | $301 → $315 |
| 2026-10-09 | Morgan Stanley | Target raised | Overweight | $330 → $337 |
| 2026-10-07 | Barclays | Target raised | Equal-Weight | $270 → $281 |
| 2026-10-05 | UBS | Target raised | Neutral | $260 → $270 |
| 2026-10-05 | TD Cowen | Target raised | Buy | $292 → $300 |
| 2026-10-02 | Wells Fargo | Initiated | Overweight | $301 |
Total return (dividends reinvested) (CME)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | +18.2% | +73.2% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +18.3% | +11.6% |
| Volatility (annualized) | 24.5% | 20.7% |
| Max drawdown | -31.1% (Mar 2026→Jun 2026) | -31.2% (Mar 2022→Oct 2022) |
CME revenue by product line (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Interest from Performance Bonds | $1.39B | 81.4% | -6.6% |
| Clearing and transaction fees | $1.35B | 79.3% | -2.6% |
| Market data and information services | $238.1M | 14.0% | +20.2% |
| Other | $115.6M | 6.8% | +9.2% |
| Total revenue | $1.71B | 100% | — |
As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).
CME suppliers, customers and competitors (named in its 10-K)
| Relationship | Company | Sentence in the filing |
|---|---|---|
| Partner | Alphabet (Google) (GOOGL) | “Partnership with Google Cloud - In 2021, we entered into a 10-year strategic partnership with Google Cloud to accelerate our move to the cloud.” |
| Partner | S&P Dow Jones Indices | “Through our joint venture with S&P Global, S&P Dow Jones Indices LLC, we have a long-term, ownership-linked, exclusive license to list futures and options based on the S&P 500 Index and certain other S&P indices.” |
| Partner | Flutter Entertainment plc (FLUT) | “Our joint venture with FanDuel, a part of Flutter Entertainment plc, launched in December 2025.” |
| Partner | Fixed Income Clearing | “We have enhanced our arrangement with FICC through the partnership with The Depository Trust & Clearing Corporation (DTCC) to offer enhanced capital efficiencies to our eligible clearing firms.” |
| Partner | The Depository Trust & Clearing | “We have enhanced our arrangement with FICC through the partnership with The Depository Trust & Clearing Corporation (DTCC) to offer enhanced capital efficiencies to our eligible clearing firms.” |
| Partner | FanDuel Prediction Markets | “FanDuel Prediction Markets LLC, which is part of our joint venture with FanDuel, is a registered FCM.” |
Quoted from the company's 10-K filed Feb 26, 2026.
CME analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Dec 2026) | $3.03 | $2.97 | +1.9% | $1.77B | 14 |
| Next quarter (ends Mar 2027) | $3.32 | $3.29 | +1.2% | $1.86B | 12 |
| Current fiscal year (ends Dec 2026) | $12.42 | $12.27 | +1.2% | $7.10B | 15 |
| Next fiscal year (ends Dec 2027) | $13.20 | $12.94 | +2.0% | $7.45B | 16 |
CME options: expected move
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Oct 30, 2026 | 7 | 25.7% | ±3.1% |
| Nov 6, 2026 | 14 | 26.6% | ±4.3% |
| Nov 13, 2026 | 21 | 26.4% | ±5.2% |
| Nov 20, 2026 | 28 | 24.6% | ±5.6% |
| Nov 27, 2026 | 35 | 25.1% | ±6.3% |
| Dec 4, 2026 | 42 | 25.0% | ±6.8% |
| Dec 18, 2026 | 56 | 23.9% | ±7.7% |
| Jan 15, 2027 | 84 | 24.7% | ±9.6% |
30-day implied volatility 24.9% vs 23.4% realized over the last 30 trading days. Put/call ratio (volume) 0.82. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 23, 2026 at 09:16 UTC)
| Price | USD 305.98 |
|---|---|
| Change | ▲ 3.45% (up) |
| Previous Close | USD 295.79 |
| Open | USD 301.99 |
| Day Range | USD 300 – 307.26 |
| 52-Week Range | USD 218.31 – 329.16 |
| Volume | 2,294,409 shares |
| Market Cap | $110.02B |
| Exchange | NMS |
Technical Analysis (CME)
Nexqual's technical model rates CME "BUY" based on 5 bullish and 3 bearish signals across 127 daily candles, as of October 23, 2026 at 09:16 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 76.12 (overbought) |
| vs SMA50 | Above (USD 276.6) |
| MACD | 7.34 (positive) |
Analyst Ratings (CME)
Wall Street analysts rate CME "Buy" based on 17 analysts, with a mean price target of USD 313.81 (range USD 227–367), per Nexqual as of October 23, 2026 at 09:16 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 17 |
| Mean Target | USD 313.81 |
| High Target | USD 367 |
| Low Target | USD 227 |
| Buy / Hold / Sell | 9 / 6 / 2 |
Earnings (CME)
| Next Earnings Date | 2026-10-21 |
|---|---|
| EPS Estimate | USD 3.03 |
| Revenue Estimate | $1.77B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-09-30 | USD 3.02 vs est 2.99 ▲ beat |
| 2026-06-30 | USD 2.99 vs est 2.91 ▲ beat |
| 2026-03-31 | USD 3.36 vs est 3.37 ▼ miss |
| 2025-12-31 | USD 2.77 vs est 2.74 ▲ beat |
Source: Nexqual, October 23, 2026 at 09:16 UTC.
Financials & Fundamentals (CME)
| Total Revenue | $6.96B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +13.20% |
| Gross Margin | +100.00% |
| Operating Margin | +65.70% |
| Profit Margin | +63.46% |
| ROE | +16.13% |
| Debt / Equity | 0.13 |
| Current Ratio | 1.02 |
| Total Cash | $2.33B |
| Total Debt | $3.43B |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | $4.21B (62.2% of revenue) |
Source: Nexqual, October 23, 2026 at 09:16 UTC.
Financial Health Score (CME)
Nexqual rates CME Group Inc.'s overall financial health "Strong" across five dimensions, as of October 23, 2026 at 09:16 UTC.
| Growth | Solid — Revenue +6% YoY (annual) |
|---|---|
| Profitability | Strong — Operating margin 66% |
| Balance Sheet | Strong — $2.33B cash vs $3.43B debt |
| Cash Flow | Strong — FCF $4.21B (last 4 quarters to Jun 2026, SEC), 62% margin |
| Efficiency | Solid — ROE 16%, ROA 1.5% |
Ownership (CME)
| Insider Ownership | +0.44% |
|---|---|
| Institutional Ownership | +91.50% |
| Shares Outstanding | 359.58M |
| Float | 353.11M |
| Short % of Float | +1.71% |
Source: Nexqual, October 23, 2026 at 09:16 UTC.
Leadership (CME)
CME Group Inc. is led by Terrence A. Duffy, Chairman & CEO, per Nexqual as of October 23, 2026 at 09:16 UTC.
| Chairman & CEO | Terrence A. Duffy |
|---|---|
| Senior MD, President & CFO | Lynne C. Fitzpatrick |
| Senior MD, Group COO & Global Head of Clearing | Suzanne Sprague |
| Senior Managing Director of Corporate Marketing & Communications | Anita Liskey |
Major Backers & Investors (CME)
Notable institutional backers of CME Group Inc. include Morgan Stanley, Capital Group, JPMorgan, according to Nexqual as of October 23, 2026 at 09:16 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Morgan Stanley | 2.71% |
| Capital Group | 1.9% |
| JPMorgan | 1.6% |
| Sanders Capital, LLC | 1.41% |
| NORGES BANK | 1.34% |
| Fidelity | 1.31% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 9.13% |
| BlackRock | 8.5% |
| State Street | 4.55% |
| Geode Capital | 2.58% |
Source: Nexqual, October 23, 2026 at 09:16 UTC.
From CME Group Inc.'s Latest SEC 10-K Filing (filed 2026-02-26)
Key Strengths & Strategy (as disclosed to the SEC)
- Data Services Business: We offer a variety of data products and services through industry-leading data platforms and third-party distribution partners, which are designed to meet the risk-management, trading, investment and business needs of our global customer base.
- Significant progress was achieved during 2025 in moving our core, non-latency sensitive applications, including those supporting clearing and market data, to the Google Cloud.
- As customers continue to leverage cloud technology to improve and evolve their businesses, CME Group has taken a leading role by becoming the first derivatives marketplace to provide live market data natively on the Google Cloud.
- CME Group is also the distributor of leading benchmark equity and commodity indices on behalf of third parties, as well as a distributor and licensor of our own proprietary benchmarks and indices, including CME Term SOFR Reference Rates (CME Term SOFR) and Term €STR Reference Rates, which adhere to the International Organization of Securities Commissions Principles for Financial Benchmarks and are administered by our UK regulated subsidiary, CME Benchmark Administration Limited (CME Benchmark).
Partnerships
- Partnership with Google Cloud - In 2021, we entered into a 10-year strategic partnership with Google Cloud to accelerate our move to the cloud.
- We have a broad distribution network around the globe comprised of a combination of internal and external channels and proprietary front-end capabilities. •Enhancing our retail strategy focusing on the growth of top-tier and large new-to-futures brokers and broadening our contract offerings to better align with the investment strategies favored by retail traders.
Legal & Regulatory Risks (Item 1A, quoted)
- Our market data revenues may be reduced by decreased demand, poor overall economic conditions, regulatory changes or a significant change in how market participants trade and use market data.
- Our risk management, compliance and monitoring programs might not be effective and may result in outcomes that could adversely affect our reputation, financial condition and operating results.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ICE | Intercontinental Exchange Inc. | USD 163.84 | ▲ 3.9% |
| SPGI | S&P Global Inc. | USD 453.1 | ▲ 2.24% |
| MCO | Moody's Corporation | USD 491.05 | ▲ 2.08% |
| NDAQ | Nasdaq, Inc. | USD 103.3 | ▲ 7.47% |
| MSCI | MSCI Inc. | USD 620.24 | ▲ 2.61% |
| COIN | Coinbase Global, Inc. | USD 169.09 | ▼ 4.51% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:16 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt